findmyKOL
Clinical trialNCT00615173CompletedPhase 3Interventional

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

SponsorSun Yat-sen UniversityEnrollment81Kidney DiseasesLupus NephritisTacrolimusInduction PhaseMaintenance Phase
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jian Chen, MD

    Department of Nephrology, Fuzhou Military General Hospital

    Principal Investigator
    clinicaltrials.gov ↗
  • Jin li Zhang, MD

    Department of nephrology, People's Hospital of Yunnan Province

    Principal Investigator
    clinicaltrials.gov ↗
  • Jun zhou Fu, MD

    Department of Nephrology,1st People's Hospital of Guangzhou

    Principal Investigator
    clinicaltrials.gov ↗
  • Ping Fu, MD

    Department of Nephrology, West China Hospital of Sichuan University

    Principal Investigator
    clinicaltrials.gov ↗
  • Tan Qi Lou, MD

    Department of Nephrology, 3rd Affiliated Hospital of Sun Yet-Sen University

    Principal Investigator
    clinicaltrials.gov ↗
  • Wei Shi, MD

    Department of Nephrology, People's Hospital Guangdong Provincial

    Principal Investigator
    clinicaltrials.gov ↗
  • Xue Qing Yu, MD

    Department of Nephrology, 1st Affiliated Hospital, Sun Yat-Sen University

    Principal Investigator
    clinicaltrials.gov ↗
  • Yao zhong Kong, MD

    Department of Nephrology, 1st People's Hospital of Foshan

    Principal Investigator
    clinicaltrials.gov ↗
  • Yun Hua Liao, MD

    Department of Nephrology, 1st Affiliated Hospital of Guangxi Medical University

    Principal Investigator
    clinicaltrials.gov ↗
  • Zheng rong Liu, MD

    Department of Nephrology, Nanfang Hospital of Southern Medical University

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the 1st Affiliated Hospital, Sun Yet-Sen University

    Guangzhou, Guangdong, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2006
Primary completion
30 Sept 2008
Completion
30 Sept 2008
Last update posted
29 Oct 2008
Registered enrollment
81
Registry id
NCT00615173
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.